The panel will discuss agency experience on merger remedies: which remedies have worked, and which are failures? The evolution of remedy policy over time will be a centerpiece of the discussion. Also, what can be done to augment our knowledge on remedy efficacy? How might agencies improve in this area?
This program is sponsored by the Thought Leadership In Antitrust Law & Academia Task Force
The content of this program does not meet requirements for continuing legal education (CLE) accreditation. You will not receive CLE credit for participating.
